 The FDA has given 510k clearance to SeaSpine Holdings Corporations NASDAQ:SPNE 7D Percutaneous Spine Module for minimally invasive surgery. This news follows SeaSpines recent acquisition of 7D Surgical, a Toronto-based company that develops advanced optical technologies and machine vision-based registration algorithms for surgical navigation to improve patient care. 